Male NMRI or BALB/c mice developed severe liver injury as assessed by transaminase release within 8 h when an intravenous dose greater than 1.5 mg/kg concanavalin A (Con A) was given. Histopathologically, only the liver was affected. Electron micrographs revealed leukocyte sticking to endothelial cells and bleb formation of hepatocytes. The hepatotoxicity of the lectin correlated neither with its agglutination activity nor with its sugar specificity. Administration of 0.5 mg/kg dexamethasone or 50 mg/kg cyclosporine A or 50 mg/kg FK 506 (Fujimycin) resulted in protection of the animals whereas indomethacin pretreatment failed to protect. Con A hepatitis was accompanied by the release of IL-2 into the serum of the animals. Mice with severe combined immunodeficiency syndrome lacking B as well as T lymphocytes were resistant against Con A. Athymic nude mice with immature T lymphocytes were also resistant. Pretreatment of mice with an antibody against T lymphocytes fully protected against Con A as did monoclonal anti-mouse CD4. Monoclonal anti-mouse CD8 failed to protect. Pretreatment of mice with silica particles, i.e., deletion of macrophages, prevented the induction of hepatitis. These findings provide evidence that Con A-induced liver injury depends on the activation of T lymphocytes by macrophages in the presence of Con A. The model might allow the study of the pathophysiology of immunologically mediated hepatic disorders such as autoimmune chronic […] 
Introduction
Toxic liver disease represents a worldwide health problem in humans, which can be managed pharmacologically in only a few cases. Development ofnew drugs depends primarily on the availability of suitable animal models. Until now, the commonly used induction of toxic liver injury by xenobiotics hardly represents the clinical situation in human beings.
The pathophysiology ofliver disease includes complex phenomena such as interorgan interrelationships on humoral basis, the highly sophisticated morphological organization of the organ itself, and the integrity of metabolic pathways and their regulation in the individual cell types ofthe liver. Because of these circumstances, the development ofhepatic injury cannot be easily studied in cellular systems. The currently established liver disease models in experimental animals are either based on the adverse effects of model hepatotoxins or take advantage of inherited metabolic disorders affecting the liver. Either model is prone to the limitations inherent to the experimental approach. Recently, this model spectrum has been extended by an acute inflammatory liver disease induced by LPSs from gram-negative bacteria in galactosamine-sensitized rodents, which is likely to be based on production and biological action of endogenous mediators. Among these mediators, leukotriene D4 and tumor necrosis factor-a (TNF)1 have been identified in a causal sequence leading to hepatitis (1, 2) . Previous work by others suggests that macrophages represent a cell type that is primarily responsible for this pathophysiology as a recipient and sender of humoral signals (3) .
Despite detailed knowledge about the reaction of lymphocytes to the inflammatory response, little is known about the contribution ofthis cell type to liver disorders. The widespread use ofconcanavalin A (Con A) as a potent agent that stimulates in vitro the release of a broad spectrum of lymphokines from lymphocytes and other mononuclear cells (4) Eight hours after Con A challenge, mice were sacrificed by cervical dislocation. Blood was withdrawn by heart puncture into 2.5% heparin. Lung, heart, liver, spleen, and kidneys were removed and fixed in 4% Formalin/PBS. The extent of liver injury was assessed by determination of serum alanine aminotransferase (ALT), serum aspartate amino transferase (AST), and serum sorbitol dehydrogenase (SDH) activities according to Bergmeyer (5) . For histopathological evaluation 4-,am sections were stained with hematoxylin/eosin.
Cytokine assays. TNF in serum of mice was determined as described in reference 6, serum IL-1 was assessed in a proliferation assay using the T cell clone D1OG4. 1 (7) .
IL-2 in serum of mice was determined essentially as described in reference 8 with the modification of using the mouse cytotoxic T cell clone CTLL-2. Recombinant murine IL-2 (Boerhinger, Mannheim) was used as a standard. A monoclonal antibody directed against the murine IL-2 receptor (Boehringer, Mannheim) was used for checking specifity.
Proliferation assay. For scanning electron microscopy, after osmification following the steps mentioned above, samples were cryoprotected with 10%, 20%, and 30% glycerol (each step for 30 min, room temperature) and cryofixed in liquid propane. After transfer to liquid nitrogen they were broken up with a precooled razor blade. Dehydration was carried out in absolute methanol at -80'C for 2 d. After gentle warming up, specimens were critical-point-dried, mounted on aluminum stubs, sputtered with 15 nm gold-palladium and viewed in a scanning electron microscope (model 505, Philips Electronic Instruments, Mahwah, NJ).
Because ofthe massive lesions in liver tissue observed 8 h after Con A treatment (such as obstruction ofmicrocirculation), fixation was also carried out by immersion with 2.5% glutaraldehyde in sodiumcacodylate buffer for 2 h. The remaining steps were carried out as mentioned above.
Statistics. The results were analyzed according to Student's t test. Data of transaminases and SDH are expressed as mean ±SEM; P < 0.05 was considered to be significant.
Results
Dose dependence of Con A-induced liver injury. When mice were intravenously injected with Con A, the animals suffered from acute liver failure. Histopathological inspection of the major organs showed no overt signs of organ injury except the liver. A dose > 1.5 mg/kg Con A led to a significant increase of serum transaminases and SDH activity within the next 8 h after the administration of the agent (Table I) . No significant increase in y-glutamyl transpeptidase activity or in alkaline phosphatase activity was found. This enzyme pattern and the AST/ALT ratio of 0.6 suggests that a liver-specific lesion of the inflammatory rather than the necrotic type had been provoked by Con A. Boiled Con A preparations were ineffective.
Morphological findings. In stained thin sections of livers from Con A-treated mice, single small group necrosis became occasionally detectable by light microscopy. Portal areas as well as the parenchyma of the livers from Con A-treated mice were only scarcely infiltrated by leukocytes. To resolve the discrepancy between the extent of liver injury assessed by enzyme release as compared with apparently moderate histopathologically detectable lesions, a detailed EM examination was carried out. With this technique, severe morphological disintegration of the hepatic microarchitecture and cellular lesions were detected.
The freeze fracture technique used in combination with scanning EM investigations of liver tissue permitted an overview of morphological changes after Con A treatment. Compared with an untreated control liver (Fig. 1 a) , the micrograph in Fig. 1 b revealed , as the most striking phenomenon 4 h after Con A challenge, a pronounced sticking of leukocytes to the hepatic endothelium. At this time, disruption of endothelial cells or hepatocytes was hardly seen. A frequent observation was a direct interaction between activated macrophages and lymphocytes (Fig. 1 c) . Eight h after treatment, lymphocytes were found to stick to hepatocytes whose sinusoidal surface showed a rough appearance (Fig. 2 b) compared with the flattened one seen in the control (Fig. 2 a) . In comparison to hepatocytes from control samples with their microvilli protruding into the space ofDisse ( Fig. 2 a and Fig. 3 a) , the cell membrane of hepatocytes from Con A-treated animals had undergone N-acetyl-n-galactosamine; n-GlcNAc: N-acetyl-n-glucosamine; NeuNAc: N-acetyl-neuraminic aicd. * P . 0.05 vs. untreated control. * RAA:
relative agglutination activity with erythrocytes (given by the supplier for each lot).
drastic changes. The surface was covered with cell debris and bleb formation was observed on hepatocytes (c.f., Fig. 2 b and Fig. 3 b) . Cell death of hepatocytes was unequivocally confirmed by transmission electron micrographs taken from mouse livers 8 h after challenge. Although control hepatocytes showed intact ultrastructural details such as microvilli, dense cytoplasma, and well-preserved mitochondria (Fig. 3 a) , in livers from Con A-treated animals, the sinusoidal parts of the hepatocytes showed severe damage with ruptures of the cell membrane, blebs, and loss of cytoplasma (Fig. 3 b) .
Specificity of the lectin. Table II shows results of experiments that were carried out to evaluate the specificity of the lectin with respect to its capability of inducing liver damage. The results show that only Con A and PHA induced hepatotoxicity in equivalent doses. Succinyl Con A, which preserves its sugar specificity but is devoid of agglutination activity as compared with Con A, did not induce any significant reaction of the liver. On the other hand, Viciafaba lectin, which shares the sugar specificity of Con A and exceeds the agglutination activity of Con A, also had no effect in the animals. These findings and further data in Table II Specifictyfor the sugar-binding site. We wondered whether the capacity of Con A to bind to mannosyl residues was a prerequisite for its hepatotoxic in vivo properties. Therefore, we preincubated Con A with strong ligands for its sugar-binding site. The coadministration of Con A with a-n-mannoside or methyl a-n-mannopyranoside prevented the induction of hepatic injury by the lectin (ALT: Con A alone: 2,095±633 [U/1, a-n-mannose + Con A: 300±234 [U/1], a->-mannopyranoside + Con A: 30±9 [U/1], n = 6-10, P < 0.05 vs. Con A alone). We therefore conclude that a free sugar-binding site is required for the adverse effects of Con A on the liver. Pharmacological interventions. The known capability of Con A to release lymphokines from lymphocytes and to induce their proliferation (for review see reference 10) prompted us to carry out some pharmacological intervention experiments to get more insight into the pathobiochemistry ofthis model. The results in Table III indicate that pretreatment of mice with either dexamethasone, FK 506, cyclosporine A protected against liver injury induced by Con A. The morphological appearance of cyclosporine A-protected livers was not distinguishable from untreated control livers. On the other hand, high doses ofindomethacin sufficient to inhibit eicosanoid synthesis (1 1) failed to show any significant effect. We conclude from this inhibition pattern that dexamethasone, rather than acting as an antiinflammatory agent, FK 506, as well as cyclosporine A, inhibited Con A-induced hepatitis by immunosuppressive actions directed towards lymphocytes. Several reports are available showing that cyclosporine A or FK 506 preferentially inhibit T cell activation at the level oflymphokine production by an inhibition of transcription (12) (13) (14) (15) (16) . We therefore decided to further investigate the involvement of lymphocytes by using mice with different genetic lymphocyte defects.
Lack ofinduction ofhepatitis in lymphocyte-deficient mice. The results shown in Table IV protected against the hepatotoxic effects ofCon A. In an analogous experiment it was shown that athymic nude mice, which bear functionally defective, immature T lymphocyte populations (18) are also resistant against Con A-induced hepatitis. These findings provide strong evidence that T lymphocytes are involved in the pathogenesis of Con A-induced hepatitis.
Immunological interventions. The finding that T-cells are involved in Con A-induced liver injury was further confirmed by immunological intervention studies: pretreatment of mice with a monoclonal antibody which in vivo destroys Thy 1.2 antigen-bearing T cells abrogated the susceptibility of these animals towards the hepatotoxic properties of Con A (Table  V) . Proliferation capacity of spleen cells of anti-Thy 1.2 pretreated BALB/c mice towards Con A was tested in vitro and was found to be reduced by 83% compared with the control. FACS analysis of spleen cells of untreated BALB/c mice showed agreement with published data in that 37.3±5.1% (n = 3) ofthe cells were stained by a monoclonal anti-mouse Thy 1.2 fluorescein antibody (19) . In contrast, only 6.8±3.6% (n = 3) of the spleen cells of anti-Thy 1.2 pretreated BALB/c mice were stained by anti-Thy 1 .2-fluorescein antibodies. This corresponds to a reduction of 82% of anti-Thy 1.2 fluorescein (Table V) . In contrast, a MAb directed against the CD8-glycoprotein failed to protect against Con A hepatitis. We conclude from these findings that, in our model, the activation of T helper (TH) cells by Con A is obligatory to start the immunological response and finally to result in injury.
Moreover, the known in vivo destruction of macrophages by silica particles (20) (21) (22) ) resulted in prevention of Con A-induced liver injury (ALT: 150±36 [U/l] compared with the Con A control with 6.960±1.710 [U/1, n = 6, P < 0.05). This finding demonstrates the ancillary involvement of macrophages in the induction ofCon A hepatitis. These results suggest a mechanism of Con A-mediated organ injury involving a macrophage-TH cell interaction, which eventually leads to an activation of TH cells. Therefore, this activation step was further investigated by checking the release of IL-2 after Con A challenge.
IL-2 in sera of Con A-treated mice. The interaction between the T cell antigen receptor of CD4+ TH cells and peptides presented by major histocompatibility complex (MHC) class II molecules on macrophages is known to induce the release of IL-1 from macrophages as well as the release of IL-2 from the CD4+ cells during the initiation of TH cell proliferation. Moreover, mitogen-activated TH lymphocytes secrete IL-2 in the presence of IL-1-producing cells (23) .
In sera of Con A-treated mice, only little IL-1-activity was found (near the detection limit). Serum IL-2 activity was measurable 2 h after intervention and reached a maximum 4 h after the Con A treatment (Fig. 4) . This finding supports further evidence for the conclusion that TH cell activation is a key event in the pathogenesis of Con A-induced hepatitis.
Further discriminating experiments. It appears that the Con A model described so far is distinct from the exclusively macrophage-dependent, endotoxin-inducible hepatitis model in the galactosamine-sensitized mouse (1, 3 whether, as in the case of endotoxin (24) , these mice could be rendered resistant by pretreatment with subtoxic doses of endotoxin. Mice that had received an intraperitonal injection of 5 ,ug/kg of Salmonella abortus equi endotoxin 1 h before Con A were not tolerant against the lectin, however, they were protected against fulminant hepatitis induced by injection of 700 mg/kg D-galactosamine plus 10 ,ug/kg endotoxin (data not shown). This experiment excludes the involvement ofendotoxins in Con A-induced liver injury. Moreover, the known endotoxin-resistant mouse strain C3H/HeJ was not resistant against Con A-induced hepatitis, also suggesting that the mechanism of injury is not due to an endotoxin-mediated process. This experiment further shows that this mouse strain, in addition to NMRI and BALB/c mice, is also sensitive to Con A, i.e., that Con A sensitivity is not restricted to a certain mouse strain.
The predominant mediator of endotoxin-induced organ failure is TNFa (25) . We therefore measured serum TNF in Con A-treated animals. Despite the fact that low serum TNF activity (2.3 ng/ml total TNF within 8 h) was found, pretreatment with antibody capable of neutralizing 2.5 ,ug murine TNFa failed to protect against Con A-induced hepatitis. Therefore, it appears that TNFa is not primarily involved in this experimental disease.
Discussion
Lectins are proteins that bind to sugar residues on the surface of a wide variety ofdifferent cell types. Their biological properties include agglutination of bacterial, plant, or mammalian cells; mitogenic stimulation of T lymphocytes, which is associated with the release of biologically active polypeptides known as lymphokines; as well as the induction of cytotoxicity of lymphocytes and macrophages (for review see reference 10) . The lectin-induced cytotoxic action ofT lymphocytes affects immunologically unrelated target cells and is attributed to the ability of the lectin to bridge effector and target cells (26) and to activate effector cells, i.e., T lymphocytes for killing the target cells (27) . In this study, liver parenchymal cells were clearly identified as the target cells of the in vivo toxicity of Con A. Indeed, it is known that hepatocyte plasma membranes strongly bind Con A (28) . Moreover, Con A has been shown to bind to the insulin receptor present in liver tissue (29) .
Ultrastructural evaluation clearly revealed adhesion of leukocytes to endothelial cells as an early event in liver damage. Obstruction ofthe microcirculation by blood cells became pronounced at later times and made it impossible to perfuse livers from Con A-treated animals 8 h after challenge. The prominent feature ofthe morphologically visible lesions was the complete disintegration of the endothelium, with subsequent cellular necrosis of hepatocytes. The chronological sequence: adhesion, endothelial cell detachment, bleb formation of parenchymal cells, does in fact explain why hepatocyte cell death could not be observed by light microscopy.
Our experiments with the SCID mouse strain and athymic nude mice as well as with antibodies directed against T lymphocytes clearly identify the T lymphocyte as an effector cell in vivo. Subsidiary evidence for the involvement of T cells comes from the pharmacological intervention experiments with cyclosporine A or FK 506. It has been described that the immunosuppresive activity of cyclosporine A as well as of FK 506 is not only due to inhibition of T cell-dependent IL-2 production, but also due to inhibition of the production of lymphotoxin (TNF3) and interferon (14, 15, 30 (33) .
The finding that the liver is the target organ of Con A-induced toxicity in vivo may be due to the fact that this organ contains the majority of macrophages in the body, namely the Kupffer cells. After intravenous injection of Con A, this resident macrophage population exposed to the circulation is primarily reached by the lectin. Therefore, it also seems likely that T cell activation first starts within the liver and thus explains the distinct organotropy of Con A in terms of toxicokinetics.
Two chronic T cell-dependent liver injury models have been described so far, i.e., a bacterial cell wall-induced hepatic granuloma in genetically susceptible rats (34) as well as a murine inflammatory liver model induced by injection of liver homogenate in an adjuvant (35) . In the present investigation, not only the involvement of T cells was shown, but also their activation (as demonstrated by systemic IL-2 release). The practical gain ofour T cell-mediated murine autoreactive hepatitis consists in the possibility to study cause and effect relationships in an animal model and to further explore possible intervention strategies by testing immunosuppressive drugs.
The experimental liver injury described here is of considerable interest as relates to the pathophysiology of autoimmune diseases in man. An example is chronic active hepatitis (36) , a condition that leads to progressive destruction of liver paren-chymal cells by activated T cells. The pharmacological intervention profile obtained here against Con A-induced hepatitis exhibits close analogies to the efficacy ofcyclosporine A against experimental allergic encephalomyelitis in rats (37) as well as to successful treatment of autoimmune diseases in man with FK 506 (38) . We consider the Con A-induced hepatitis as a disease model where self or foreign antigen presentation by macrophages and recognition by TH lymphocytes is mimicked by the lectin Con A at the final step of a common activation pathway. This sequence ofcellular activation ofthe reticuloendothelial system may be relevant for many autoimmune diseases, including systemic lupus erythematodes, rheumatoid arthritis, type I diabetes, and multiple sclerosis.
